Medical and Pharmaceutical NRx Pharmaceuticals submits NDA for intravenous ketamine drug This therapeutic is specifically designed for suicidal depression Rowan DunneMarch 19, 2025
Canada Algernon receives approval to conduct DMT study in the Netherlands New clinical research will assess efficacy of IV formulation for the treatment of strokes Rowan DunneSeptember 12, 2022